4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-002895
EVP, COO, Head of Commercial sold 532 shares at $17.13 ($9,113)
- EVP, COO, Head of Commercial acquired 1,286 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, Head of Commercial | 2023-01-06 | Option exercise | +1,286 | 5,081 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-01-09 | Sale | −532 | $17.13 | $9,113 | 4,549 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, Head of Commercial | 2022-01-06 | Option exercise · Restricted Stock Units | −1,286 | 2,573 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-01-06 | Option exercise · Restricted Stock Units | −1,286 | 1,287 | D | ||
| Open-market sales · 532 sh · avg $17.13 · $9,113 | |||||||
Loading xslF345X03/doc4.xml…